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ABSTRACT
We report a very rare condition of idiopathic intracranial pachymeningitis (IIP) in a 66-year-old
lady who had been on continuous ambulatory peritoneal dialysis (CAPD) for 3 years. Of the less
than 20 reported cases of IIP in literature, this is a second case of IIP occurring in uremic patients.
The presentation in this lady was drowsiness, hallucination and an abnormal afferent pupillary
reflex. The diagnosis was made by magnetic resonance (MR) imaging which showed diffusely
thickened meninges, and meningeal biopsy showed chronic fibrotic change, with scattered
mononuclear cells without significant inflammatory element. There was transient symptomatic
improvement with steroid therapy but she deteriorated 6 months later and finally died 15 months
after steroid therapy.
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CASE HISTORY
Continuous ambulatory peritoneal dialysis (CAPD) was
commenced in a 66-year-old lady with history of old
minor stroke in 1994 for end-stage renal failure from
chronic glomerulonephritis. Immune markers were
unremarkable. From 1994 to 1996, Kt/V was kept above
1.8. She developed diabetes mellitus with fatty liver
changes requiring low dose insulin in 1995. In 1996, she
had postural dizziness from postural hypotension.
Autonomic neuropathy was diagnosed clinically. She also
has an episode of right hemiparesis in April 1996;
computerized tomographic (CT) scan of brain showed
left internal capsule infarct.
In January 1997, she developed headache, vomiting and
hallucination. Noncontrast CT brain was unremarkable.
Lumbar puncture showed an elevated cerebrospinal fluid
(CSF) protein of 1.83 g/L, slight pleocytosis (WCC 12 x
106/L) and normal glucose level. CSF cultures for
bacteria and mycobacterium were negative. She was
treated as bacterial meningitis with high dose penicillin
G and cefotaxime with some apparent improvement.
Three months later, she was found to have early
"Parkinsonism" features with cogwheel rigidity and right
upper limb tremor, benzhexol was given. Cisapride was
also prescribed for her recurrent epigastric discomfort.
In June 1997, she was noticed to have memory
deterioration and decreased mobility resulting in chair-
bound. In August 1997, she developed flavobacteria spp
peritonitis. Intraperitoneal vancomycin and tobramycin
were given and peritonitis responded. However she was
found to be confused with paranoid ideas 1 week after
treatment. There was no abnormality in serum sodium,
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potassium and calcium levels. Mental state deteriorated
gradually and she became semicomatose. A transient
right afferent pupillary defect was noticed. CSF from
lumbar puncture showed a markedly elevated protein
level of 4.43 g/L, white cell count 18 x 106/L (N 77%, L
13%, M 8%) and normal glucose level. CSF cultures for
acid fast bacilli, fungus and virus were negative. There
was no evidence of malignancies, autoimmune diseases
or syphilis. Anti-PR3, anti-HIV1 and 2, and anti-HTLV1
were negative. Electroencephalogram (EEG) showed
nonspecific background slow waves. CT scan of thorax
and abdomen were unremarkable. CT scan of brain was
also unremarkable apart from the old lacunar infarct and
decreased prominence of cerebral sulci. Subsequently
magnetic resonance (MR) imaging of brain revealed
diffuse grossly thickened meninges with prominent
enhancement by gadolinium (Gd) (Fig. 1). There were
also evidences of previous hematoma at the left basal
ganglion and sub-insular white matter, and scattered
multiple tiny hypointense spots compatible with
hemosiderin deposits at the subcortical region in bilateral
cerebral hemispheres and the left side of cerebellum
representing previous insult with associate bleeding.
Meningeal biopsy revealed chronic fibrotic change of
the dura and hemosiderin deposition in the arachnoid
vascular connective tissue indicating old hemorrhage.
There were scattered mononuclear cells and giant cells
of non-specific reactive changes without significant
inflammatory element or evidence of herpetic infection
or granulomatous inflammation. Idiopathic intracranial
pachymeningitis (IIP) was diagnosed and she was given
a trial of prednisolone with 1 mg/kg/day. Her mental state
gradually improved to her premorbid state with coherent
speech and she was able to walk for short distances with
some support. She was maintained on a low dose
prednisolone 2.5 mg/day at 2 months.
Six months later, she developed drowsiness again and
prednisolone was increased to 10 mg/day with some
improvement. However, she still had some fluctuation
in conscious state and hallucination. By November 1998,
she became progressively unresponsive. MR imaging
brain was repeated and did not reveal any significant
changes. Prednisolone was increased to 20 mg/day
without significant improvement. She finally succumbed
on 7 January 1999, 2 years after the first presentation of
IIP and 17 months after the diagnosis was made.
Necropsy was suggested but was refused by her family
members.
DISCUSSIONS
Altered conscious state in dialysis patients is quite
common. The common causes include infective and
metabolic encephalopathy (including uremia, drug
induced, electrolyte disturbances and aluminum toxicity),
cerebrovascular diseases, subdural hematoma and
accelerated cerebral atrophy (1). The diagnosis in this
lady is IIP which is based on the circumstantial evidences
from MR imaging, lumbar puncture and meningeal
biopsy. As the name implies, IIP has isolated meningeal
thickening which may involve intracranial or extracranial
areas. It is a very rare disorder and there were less than
20 reported cases from our Med Line literature search
(2-4). There was no consistent association with other
diseases. Its etiology and pathogenesis are unknown.
Before making the diagnosis, one must actively exclude
other conditions that cause meningeal thickening:
syphilis, tuberculosis, chronic fungal infection,
sarcoidosis and multifocal fibrosclerosis. There were two
case reports of such similar pathological findings with
HTLV-1 infection (5).
From the reported cases so far, the commonest
presentation was headache. Other symptoms were related
to the entrapment or compressive effect of the thickened
meninges, namely ataxia, visual neuropathy and various
Figure 1. Images of MR imaging of brain showing diffuse
thickening of meninges. The upper panel was an axial cut T2
weighted image (left) and fluid attennation inversion recovery
(FLAIR) image (right) which showed the thickened meninges and
some subcortical ischemic changes. The lower panel was an axial
T1 weighted images, before (left) and after (right) contrast
enhancement.
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cranial nerve palsies. In our indexed patient, the main
symptoms were drowsiness and hallucination. There was
once an abnormal pupillary reflex which signified cranial
nerve involvement. The most consistent investigation
findings are raised erythrocyte sedimentation rate,
increased CSF protein (varies from normal to 4.4 g/L)
with variable pleocytosis (from 0 to 104 x 106/L). MR
imaging shows widespread meningeal thickening with
homogeneous Gd enhancement. Meningeal biopsy is
mainly used to rule out other diseases and is nonspecific
with fibrotic thickening of dura mater, infiltrated by
lymphocytes, plasma cells and a few giant cells, together
with scattered areas of necrosis.
The disease usually runs an indolent course from 1 to 10
years. In our patient, the disease should have preceded
the diagnosis for more than a year. The so-called
"bacterial meningitis" with symptoms of headache and
hallucination was more likely an early presentation of
IIP. The apparent improvement after antibiotic therapy
was probably due to the fluctuation of symptoms of the
disease. Up till now, there is no definite treatment for
IIP. If hydrocephalus happens as a complication, surgery
is the treatment of choice. Symptoms usually improve
with steroid, but there is no consensus on the dose and
duration of treatment. Other less effective treatments
include azathioprine and radiotherapy. The meningeal
thickening on imaging is not responsive to treatment and
does not parallel with the clinical course.
The first case of IIP occurring in uremic patients was
described in 1975 in a hemodialysis patient (2). This is a
second case of IIP. The first case of IIP that occurred in
uremic patients was a 50-year-old man with unknown
cause for his renal failure and had received 1.5 years of
hemodialysis before he presented with cranial nerves
palsies which included vagus nerve palsy, blindness with
loss of afferent pupillary reflex. He died 3 months after
the onset of blindness. Necropsy showed a large recent
intracerebral hematoma involving the surface and
extended deeply into the right cerebral hemisphere and
diffuse markedly thickened dura mater. This was
probably the direct cause of death. There was thickened
dura mater with infiltrates of chronic inflammatory cells
including lymphocytes, plasma cells and scattered
eosinophils. No microbiological cause was identified
including mycobacterium, fungi, and pyogenic bacteria.
The term hypertrophic granulomatous cranial
pachymeningitis was given and this condition was
renamed IIP as there are more cases of similar
pathological findings with similar clinical presentation
and the pathological condition described subsequently.
Though by definition of an idiopathic condition, an
underlying infective cause could not be identified, a
response to an unidentified agent is still a possibility as
HTLV-1 infection has been shown to be related to such a
similar pathological condition in two patients (5). As
uremia is a form of immunosuppressive state, it may
predispose patients to such an unidentified agent. It is
also interesting to note that in both cases, there was
evidence of recent or previous intracerebral hematoma.
It may just represent a coincidence or it may point to a
pathological link between the two though meningeal
thickening is not a feature of intracerebral hemorrhage.
It has to be pointed out that the diagnosis of IIP can be
easily missed with CT scan. MR imaging is much more
sensitive to pick up this condition (6). As dialysis patients
are predisposed to various conditions affecting the central
nervous system function, a MR imaging of brain should
be considered as an essential neurological investigation
when the picture cannot be adequately explained by CT
scan or CSF findings.
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